YOUR BUSINESS AUTHORITY
Springfield, MO
Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.
Novartis is offering $73 per share, a premium of around 142%.
Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.
Read more from Quartz.
Evergreen Hair House opened; the Ozark Chamber of Commerce moved to a new home; and Dirk’s Tavern LLC got its start on C-Street.
Wendy’s franchisee ordered to pay $7M over harassment, PPP fraud accusations
Former employees allege mistreatment at The Kitchen
Missouri man sentenced for PPP fraud
27North celebrates opening of new HQ with news of expansion
Updated: First Watch business partner sues another for breach of fiduciary duty, fraud